Less Ads, More Data, More Tools Register for FREE

Pin to quick picksNanoco Regulatory News (NANO)

Share Price Information for Nanoco (NANO)

Share Price is delayed by 15 minutes
Get Live Data
2.59    -0.31 (-10.69%)
Bid:
2.60
Ask:
2.91
Spread: 0.31 (11.923%)
Market Cap: £4.73m
NANO Live PriceLast checked at - London Stock Exchange

Intraday Nanoco Share Chart

Board Changes

18 May 2016 07:00

RNS Number : 5341Y
Nanoco Group PLC
18 May 2016
 

For immediate release

18 May 2016

 

 

 

 

NANOCO GROUP PLC

("Nanoco" or the "Company")

 

Board Changes

 

Nanoco Group plc (LSE: NANO), a world leader in the development and manufacture of cadmium-free quantum dots and other nanomaterials, announces that its Chairman, Tony Clinch, has resigned as a director after six years on the Company's Board, a period during which he has led the Company through key corporate milestones including the move from AIM to the Official List and from an exclusive to a non-exclusive commercialisation strategy in the display market.

Tony joined Nanoco's Board as a Non-Executive Director in March 2010 and was appointed Chairman in April 2013.

Chris Richards, who joined Nanoco's Board as a Non-Executive Director in November 2015, has been appointed Chairman.

The above Board changes are taking place with immediate effect.

Michael Edelman, Nanoco's Chief Executive Officer, said: "On behalf of the Board, I would like to express sincere thanks to Tony Clinch for the major contribution he has made to Nanoco's development in the past six years, most recently as Chairman. In this role, he has provided wise counsel on the commercial transition of the Company in the display market, opening up new commercial opportunities through a non-exclusive licensing strategy. We thank Tony for his dedication to Nanoco and wish him well in his future endeavours.

"I would also like to welcome Chris Richards, a Non-Executive Director for the past six months, to the role of Chairman. I'm confident that he will build on the platform that Tony has created, and guide us in the exploitation of Nanoco's world-leading technology through multiple channels in the display market and in our other target markets."

 

 

For further information, please contact:

 

Nanoco

Tel: +44 (0) 161 603 7900

Michael Edelman, Chief Executive Officer

David Blain, Chief Financial Officer

Caroline Watson, Investor Relations Manager

cwatson@nanocotechnologies.com

 

Tel: + 44 (0) 7799 897357

Canaccord Genuity - Joint Broker

Tel: +44 (0) 20 7523 8000

Simon Bridges

Cameron Duncan

Mark Whitmore

Liberum - Joint Broker

Tel: +44 (0) 20 3100 2000

Neil Patel

Richard Bootle

Steven Tredget

Buchanan

Tel: +44 (0) 20 7466 5000

Mark Court / Sophie Cowles / Stephanie Watson

 

 

 

Notes for editors:

 

About Nanoco Group plc

Nanoco is a world leader in the development and production of cadmium-free quantum dots and other nanomaterials for use in multiple applications including LCD displays, lighting, solar cells and bio-imaging. In the display market, it has a non-exclusive manufacturing and marketing licensing agreement with The Dow Chemical Company.

 

Nanoco was founded in 2001 and is headquartered in Manchester, UK. It has production facilities in Runcorn, UK, and a US subsidiary, Nanoco Inc, based in Concord, MA. Nanoco also has business development executives in Japan, Korea and Taiwan. Its technology is protected worldwide by a large and growing patent estate.

 

Nanoco is listed on the main market of the London Stock Exchange and trades under the ticker symbol NANO. For further information please visit: www.nanocogroup.com.

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
BOAEAESXFAEKEAF
Date   Source Headline
5th Nov 20197:00 amRNSFormal Sale Process as Part of Strategic Review
1st Nov 20197:00 amRNSDirector/PDMR Shareholding
1st Nov 20197:00 amRNSAnnual Report and Notice of AGM
31st Oct 201910:44 amRNSTotal Voting Rights and Share Capital
23rd Oct 201911:40 amRNSHolding(s) in Company
18th Oct 20194:35 pmRNSHolding(s) in Company
16th Oct 20197:00 amRNSPreliminary Results
10th Oct 20199:40 amRNSHolding(s) in Company
23rd Sep 20193:03 pmRNSHolding(s) in Company
23rd Sep 20193:02 pmRNSHolding(s) in Company
6th Sep 20194:35 pmRNSPrice Monitoring Extension
5th Sep 20194:35 pmRNSPrice Monitoring Extension
4th Sep 20191:00 pmRNSNotice of Results
22nd Aug 20192:00 pmRNSHolding(s) in Company
15th Aug 20197:00 amRNSYear End Trading Update and Notice of Results
1st Aug 20196:15 pmRNSHolding(s) in Company
31st Jul 20197:00 amRNSContract Liability Waived
3rd Jul 20195:50 pmRNSHolding(s) in Company
27th Jun 201912:15 pmRNSHolding(s) in Company
26th Jun 20193:20 pmRNSDirector/PDMR Shareholding
26th Jun 201911:45 amRNSHolding(s) in Company
25th Jun 201912:45 pmRNSHolding(s) in Company
24th Jun 20193:45 pmRNSHolding(s) in Company
24th Jun 20193:30 pmRNSHolding(s) in Company
24th Jun 20193:30 pmRNSHolding(s) in Company
21st Jun 20197:00 amRNSUS Customer partnership update
12th Jun 201910:25 amRNSBlock listing Interim Review
7th Jun 20194:00 pmRNSDirector/PDMR Shareholding
3rd May 20197:00 amRNSDirector/PDMR Shareholding
2nd May 20196:09 pmRNSDirector/PDMR Shareholding
18th Apr 20194:55 pmRNSDirector/PDMR Shareholding
17th Apr 20193:20 pmRNSHolding(s) in Company
17th Apr 20191:22 pmRNSHolding(s) in Company
16th Apr 20195:08 pmRNSHolding(s) in Company
11th Apr 20193:38 pmRNSHolding(s) in Company
11th Apr 20197:00 amRNSDirector/PDMR Shareholding
9th Apr 20197:00 amRNSInterim Results
1st Apr 201911:40 amRNSHolding(s) in Company
12th Mar 20197:00 amRNSDirectorate Changes
4th Mar 20197:00 amRNSNotice of Results
31st Jan 20197:00 amRNSChange of Auditor
25th Jan 20197:00 amRNSContract extension signed
4th Jan 201912:18 pmRNSHolding(s) in Company
4th Jan 20197:00 amRNSPartnership with Plessey Semiconductors
24th Dec 20187:00 amRNSMilestone Achieved
13th Dec 20183:33 pmRNSResult of AGM
13th Dec 20187:00 amRNSAGM Statement
10th Dec 20184:00 pmRNSBLOCKLISTING SIX-MONTHLY RETURN
3rd Dec 201811:18 amRNSDirector Declaration
3rd Dec 20187:00 amRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.